BUY Anthem Biosciences Limited — BOB Capital Markets
byBOB Capital MarketsHorizon: NA (inferred 1 year)21 May 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Anthem Biosciences Shares Gain 2% After Profit Rises to ₹591 Crore
NewsGoogle News·3 Aug · 2w ago
Anthem Biosciences शेअरमध्ये तेजी! FY26 मध्ये नफा ₹591 कोटींवर
NewsGoogle News·3 Aug · 2w ago
Anthem Biosciences Share Price: லாபம் **₹591 கோடி** உயர்வு! பங்கு **2%** ஏற்றம்!
NewsGoogle News·3 Aug · 2w ago
Anthem Biosciences शेअरमध्ये तेजी! FY26 मध्ये नफ्यात मोठी वाढ, पण तिमाही निकालांवर लक्ष
NewsGoogle News·31 Jul · 2w ago
Anthem Biosciences Share Price: ఏడాదికి లాభాల పంట, కానీ త్రైమాసిక ఫలితాలపై ఇన్వెస్టర్ల కన్ను!
NewsGoogle News·31 Jul · 2w ago
Anthem Biosciences Share: दमदार FY26 नतीजे, पर Q1 FY27 में आई नरमी, निवेशक इन बातों पर रख रहे नज़र
NewsGoogle News·10 Aug · 1w ago
Anthem Biosciences Limited has revised its press release regarding the unaudited consolidated financial results for the quarter ended June 30, 2026. The revised release supersedes the previous one.
BSE · Company Update·21 Jul · 4w ago
Anthem Biosciences Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The company reported revenue from operations of ₹4,182 Mn and profit after tax of
BSE · Company Update·21 Jul · 4w ago
Anthem Biosciences Limited announced the outcome of its Board Meeting held on July 21, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 3
BSE · Board Meeting·21 Jul · 4w ago
Anthem Biosciences Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report of the Statut
NSE · Outcome of Board Meeting·21 Jul · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.